Sheila Kahyaoglu, Jefferies aerospace and defense analyst, joins CNBC's The Exchange to discuss why her firm increased the ...

Shares of Zomato fell by 4.8% following Jefferies' downgrade of the stock from 'buy' to 'hold' and a 18% cut in the target ...

Key stocks recommended by Jefferies for 2025 include Mankind Pharma, JB Chemicals, and Sun Pharmaceutical Industries.

Jefferies downgraded Blue Star Ltd. to 'hold' from 'buy' after the stock rallied 140% in calendar year 2024. The stock is now ...

Investing.com-- Jefferies downgraded Indian food delivery firm Zomato Ltd (NS: ZOMT) on Monday, stating that the stock was likely to see a year of consolidation after strong gains in 2024 due to ...

Zomato receives positive outlook from analysts, maintaining "Overweight" rating with target price of 355, despite recent ...

The global brokerage firm revised the target lower, citing increasing competition as a threat to the online food aggregator’s ...

Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting ...

Jefferies Financial Group Inc. JEF is slated to report fourth-quarter and full-year fiscal 2024 (ended Nov. 30) results ...

Zomato's stock price was down 4.19% to Rs 253.75 on the Bombay Stock Exchange (BSE). Earlier, the shares of Zomato hit an ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

Procore Technologies was upgraded to Buy from Hold by Jefferies as the financial firm listed the software company among its top picks for 2025. Read more here.